Celcuity LLC

Healthcare · Biotechnology

80.00$ -4.9% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Celcuity LLC (CELC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 828 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CELC
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	6.1	5.1	12	33	32	31	29	28	26	25	23	22	20	18	17	15	13	36	43	92	86	80	72	65	176	165	154	142	191	188	293	273	245	218	184	476	467	410	828
Current Assets	–	5.9	5.0	11	33	24	23	22	23	25	24	22	21	19	17	16	14	12	36	42	91	85	79	72	65	175	164	153	142	191	188	292	272	245	218	183	475	466	409	776
Cash	–	5.9	4.9	11	32	2.6	2.6	3.2	3.8	16	15	15	16	19	17	15	14	12	35	42	90	84	78	67	57	25	34	32	26	31	31	30	13	23	16	46	74	166	145	182
Cash & Short-Term Investments	–	5.9	4.9	11	33	24	23	22	23	25	23	22	20	19	17	15	14	12	35	42	90	84	78	67	58	169	157	146	134	181	178	283	264	235	206	168	455	441	145	754
Receivables	–	–	–	–	–	–	–	–	–	–	–	–	–	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.3	0.2	0.1	0.3	0.2	0.0	–	–	0.8	–	–	–	1.6	–	–	–	–	–	–
Inventory	–	–	–	–	–	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	-0.3	–	–	–	-0.2	-0.2	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	0.1	0.1	0.3	0.3	0.3	0.4	0.7	0.8	0.8	1.2	1.1	1.1	1.0	1.0	0.8	0.6	0.6	0.5	0.6	0.4	0.3	0.5	0.4	0.3	0.3	0.2	0.2	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	50
Total Liabilities	–	0.4	0.4	7.4	0.3	0.6	0.8	1.0	1.0	0.7	1.1	1.0	1.0	1.0	0.9	0.8	1.2	1.3	1.2	16	17	17	18	19	22	42	42	43	49	51	54	116	123	130	131	139	359	366	357	841
Current Liabilities	–	0.4	0.4	0.8	0.3	0.6	0.8	1.0	1.0	0.7	0.9	0.9	0.9	0.9	0.9	0.8	1.0	1.2	1.2	1.5	2.8	2.5	3.6	4.1	6.6	6.9	5.8	7.1	13	14	17	20	26	32	33	40	39	44	33	87
Short-Term Debt	–	–	–	6.6	–	–	–	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.3
Accounts Payable	–	0.3	0.2	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.6	1.7	1.5	2.1	2.3	3.2	2.6	2.6	3.0	5.6	5.1	5.3	6.2	9.2	9.4	9.9	11	11	6.4	10	8.1
Long-Term Debt	–	–	–	6.6	–	0.0	0.0	0.0	0.0	–	0.2	–	–	–	–	–	–	–	–	14	14	15	15	15	15	35	35	36	37	37	38	96	97	98	99	99	320	322	323	753
Shareholders' Equity	–	5.6	4.7	4.3	33	31	30	28	27	25	24	22	21	19	18	16	14	12	35	27	74	69	62	53	44	134	123	110	93	140	134	177	150	116	87	44	117	101	54	-13
Retained Earnings	–	-8.3	-9.3	-11	-0.3	-2.0	-4.0	-5.8	-7.7	-9.5	-11	-13	-15	-17	-19	-21	-24	-26	-29	-43	-49	-56	-64	-74	-85	-96	-108	-123	-141	-160	-182	-205	-235	-272	-309	-354	-398	-449	-502	-581
Shares Outstanding	6.7	6.7	6.7	9.4	6.8	10	10	10	10	10	10	10	10	10	10	10	10	10	11	13	15	15	15	15	15	17	22	22	22	29	34	38	43	43	43	44	45	53	54	55

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings